Home
>
National Drug Code (NDC)
>
Abridge Cold Sore Treatment
Abridge Cold Sore Treatment - 66923-406-01 - (Benzalkonium Chloride)
Drug Information of Abridge Cold Sore Treatment
| Product NDC: | 66923-406 |
| Proprietary Name: | Abridge Cold Sore Treatment |
| Non Proprietary Name: | Benzalkonium Chloride |
| Active Ingredient(s): | 1.3 mg/g & nbsp; Benzalkonium Chloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Abridge Cold Sore Treatment
| Product NDC: | 66923-406 |
| Labeler Name: | Ranir LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333A |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110331 |
Package Information of Abridge Cold Sore Treatment
| Package NDC: | 66923-406-01 |
| Package Description: | 1 TUBE in 1 PACKAGE (66923-406-01) > 2 g in 1 TUBE |
NDC Information of Abridge Cold Sore Treatment
| NDC Code | 66923-406-01 |
| Proprietary Name | Abridge Cold Sore Treatment |
| Package Description | 1 TUBE in 1 PACKAGE (66923-406-01) > 2 g in 1 TUBE |
| Product NDC | 66923-406 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Benzalkonium Chloride |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110331 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ranir LLC |
| Substance Name | BENZALKONIUM CHLORIDE |
| Strength Number | 1.3 |
| Strength Unit | mg/g |
| Pharmaceutical Classes |
